Variant report
Variant | esv3397075 |
---|---|
Chromosome Location | chr4:97213529-97215627 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116635916 | chr4:97213555-97213556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75197549 | chr4:97213604-97213605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534567886 | chr4:97213605-97213606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548371652 | chr4:97213655-97213656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568113804 | chr4:97213664-97213665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563977592 | chr4:97213671-97213672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145316637 | chr4:97213693-97213694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147658821 | chr4:97213708-97213709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556769810 | chr4:97213726-97213727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576948475 | chr4:97213731-97213732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114357323 | chr4:97213732-97213733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557490698 | chr4:97213742-97213743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138966381 | chr4:97213750-97213751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181039504 | chr4:97213764-97213765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374064543 | chr4:97213810-97213811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561575875 | chr4:97213813-97213814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575722758 | chr4:97213827-97213828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6857113 | chr4:97213828-97213829 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs185165683 | chr4:97213887-97213888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532445359 | chr4:97213912-97213913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564450912 | chr4:97213914-97213915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528644088 | chr4:97213956-97213957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552165852 | chr4:97214085-97214086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13121111 | chr4:97214097-97214098 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547062000 | chr4:97214098-97214099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559279592 | chr4:97214117-97214118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559287283 | chr4:97214118-97214119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529871064 | chr4:97214128-97214129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs34155459 | chr4:97214136-97214137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548182759 | chr4:97214138-97214139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568285146 | chr4:97214141-97214142 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536828430 | chr4:97214164-97214165 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148971077 | chr4:97214204-97214205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548204073 | chr4:97214233-97214234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs62316820 | chr4:97214268-97214269 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs111422555 | chr4:97214303-97214304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs70948481 | chr4:97214377-97214378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs13102654 | chr4:97214482-97214483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368197978 | chr4:97214652-97214653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554772266 | chr4:97214672-97214673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138595120 | chr4:97214676-97214677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143759884 | chr4:97214678-97214679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553007690 | chr4:97214707-97214708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564836897 | chr4:97214784-97214785 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6815032 | chr4:97214830-97214831 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs377570117 | chr4:97214851-97214852 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148180305 | chr4:97214854-97214855 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189585226 | chr4:97214864-97214865 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs6815558 | chr4:97214865-97214866 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs181994635 | chr4:97214872-97214873 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 19197363 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:97212800-97214000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr4:97212800-97214800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:97214000-97214200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:97214200-97214600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:97214600-97214800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr4:97214800-97215000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr4:97214800-97215400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr4:97214800-97215400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr4:97215000-97215400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr4:97215200-97215400 | Enhancers | Left Ventricle | heart |
11 | chr4:97215200-97215600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr4:97215400-97216800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr4:97215400-97219200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
14 | chr4:97215600-97216600 | Weak transcription | Left Ventricle | heart |